2026 MGFA Registry & Real-World Data Research Funding Opportunity
Forecasted
This MGFA grant funds research using real-world and registry data to advance scientific knowledge and care for myasthenia gravis.
Funder: Myasthenia Gravis Foundation of America
Due Dates (Anticipated): July 2027 (Full application submission deadline, projected)
Funding Amounts: Up to $10,000 per award; 4 awards anticipated; 6-month project period; no indirect costs.
Summary: Supports high-impact research leveraging MG patient-reported and clinical datasets to advance understanding and care in myasthenia gravis.
Key Information: All dates are projected; check the program page for updates.
Description
This competitive research funding opportunity from the Myasthenia Gravis Foundation of America (MGFA) aims to accelerate impactful research, abstract development, and peer-reviewed publications that advance the understanding and treatment of myasthenia gravis (MG) and related neuromuscular junction disorders. The program empowers investigators to utilize unique patient-reported, longitudinal, and real-world clinical datasets—including the My RealWorld MG and Vitaccess Real MG Registry—to generate meaningful scientific insights. The initiative is designed to expand access to valuable data resources and foster the next generation of clinical investigators and scientific leaders in the MG research community.
